The Society of MSK Prize Commemorates Pediatric Oncology

In celebration and commemoration of The Society of Memorial Sloan Kettering Cancer Center’s 70th Anniversary occurring in 2016, this new prize has been established to recognize important contributions to the field of Pediatric Oncology.  Further, it will highlight the longstanding and future facing partnership between The Society and Memorial Sloan Kettering, and affirming the global leadership of MSK in the field of Pediatric Oncology. 

Dr. Richard O'Reilly
Dr. Richard O'Reilly

To highlight MSK’s dedication to education, The Society Prize will be awarded at the Annual MSK Academic Convocation to a researcher, physician, or team leader who has made a positive and lasting impact in the fight against pediatric cancer. All biomedical laboratory disciplines, as well as computational biology, epidemiology, pharmacology, radiology, palliative care, etc. are eligible, and there is no geographical limitation on who is eligible for consideration. The Society Prize will include a cash prize, as well as a physical award, and the recipient will be provided travel accommodations if needed to accept the prize at MSK’s Academic Convocation each spring. 
  
The Inaugural Society Prize recipient is Richard J. O’Reilly, MD, Chairman of MSK’s Department of Pediatrics and Director of the Bone Marrow Transplantation Program. The much beloved Dr. O’Reilly has been selected based on his transformative research accomplishments over the past 40 years and his extraordinary service to MSK’s pediatric patients and their families.

"Recognition of individuals who have made major contributions to our understanding of the pathogenesis of malignancies in childhood will provide a strong stimulus to research in this field. I expect it will also encourage many brilliant young investigators embarking on research careers to explore the causes and distinctive biology of cancers affecting developing tissues in children, and thereby accelerate progress towards their control and eradication,” said Dr. O’Reilly.

Dr. O’Reilly further commented, “At this time in our history, when the possibilities for translating discoveries into more consistently curative and less toxic treatments has never been greater, yet paradoxically, grant funds to support research, and particularly research on cancers of childhood, are contracting, the establishment of The Society of Memorial Sloan Kettering Prize in Pediatric Oncology has a singular potential to foster advances in this field."